U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA ...

Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the ...

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

US drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

HYDERABAD: Reiterating the state government’s goal to make Hyderabad the world’s “China Plus One” destination, Chief Minister ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre ...

The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further ...

US-based biopharma giant on Monday opened its new technology and innovation centre in Hyderabad with its CEO Robert Bradway ...

Weight-loss drugs aren’t just slimming waists; they create a $100 billion market opportunity. With plenty up for grabs, ...

Global biotech leader Amgen opened its $200 million technology and innovation centre in Hyderabad, a facility that will help ...